ArticleNPJ digital medicine2026
A deep learning system for bacterial identification and resistance prediction from MALDI-TOF data.
Article in NPJ digital medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry (MS) data contain underutilized information beyond species identification. We developed a deep learning system-termed ANTIBIOTIC-that identifies bacterial species, predicts antimicrobial resistance (AMR), and recommends antibiotics directly from raw MALDI-TOF MS data. Using a public dataset (DRIAMS, 2015-2018) and 89,026 MS records from a local hospital dataset (NTUHYL, 2017-2023), we built 26 LightGBM models for identifying the most prevalent bacterial species and 248 Temporal Convolutional Network models for predicting AMR across bacteria-antibiotic combinations. For bacterial identification, models achieved a median area under the curve (AUC) of 0.99 internally and 0.96 on temporally split external data. For AMR prediction, median AUC was 0.94 internally but declined to 0.55 on temporal external data, improving to 0.61 after fine-tuning with recent data. Integrating these models with a large language model enabled an antibiotic recommendation chatbot. These findings demonstrate that deep learning can leverage MALDI-TOF MS data for large-scale bacterial identification and AMR prediction, though AMR models require periodic updating to maintain performance.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.